3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Unspecified Childhood Solid Tumor, Protocol Specific
1
Smoldering Multiple Myeloma
1
Prostatic Neoplasms
1
Polycystic Ovary Syndrome
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Monoclonal Gammopathy of Undetermined Significance
1
Menstruation Disturbances
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Leukemia
1
Hodgkin Disease
1
Interventions
pembrolizumab
26
atezolizumab
14
Nivolumab
13
Gemcitabine
13
Cisplatin
10
Docetaxel
8
Carboplatin
8
avelumab
7
Mitomycin
7
epacadostat
4
cabozantinib
4
Ipilimumab
4
pemigatinib
3
Specimen Handling
3
Paclitaxel
3
Magnetic Resonance Spectroscopy
3
Bevacizumab
3
vofatamab
2
rucaparib
2
lenvatinib
2
enfortumab vedotin
2
durvalumab
2
cabazitaxel
2
bempegaldesleukin
2
Standard of Care
2
Rogaratinib
2
Ramucirumab
2
Radiation
2
Platinum
2
Pemetrexed
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Transitional Cell
×
Absorptiometry, Photon
×
Clear all
No trials found.